The trajectory of putative astroglial dysfunction in first episode schizophrenia: a longitudinal 7-Tesla MRS study

• Published in: Scientific reports Vol. 11; no. 1; p. 22333
• Main Authors: Jeon, Peter, Mackinley, Michael, Théberge, Jean, Palaniyappan, Lena
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 16-11-2021; Nature Publishing Group; Nature Portfolio
• Subjects: 631/45/882; 692/53/2423; 692/699/476/1799; Adolescent; Adult; Antipsychotic Agents - administration & dosage; Antipsychotics; Astrocytes; Astrocytes - metabolism; Cortex (cingulate); Female; Gyrus Cinguli - diagnostic imaging; Gyrus Cinguli - metabolism; Humanities and Social Sciences; Humans; Inositol; Inositol - metabolism; Longitudinal Studies; Magnetic Resonance Imaging; Magnetic resonance spectroscopy; Male; Mental disorders; multidisciplinary; Patients; Psychosis; Psychotic Disorders - diagnostic imaging; Psychotic Disorders - drug therapy; Psychotic Disorders - metabolism; Schizophrenia; Schizophrenia - diagnostic imaging; Schizophrenia - drug therapy; Schizophrenia - metabolism; Science; Science (multidisciplinary); Spectrum analysis
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-021-01773-7

Myo-inositol is mainly found in astroglia and its levels has been shown to be reduced in the anterior cingulate cortex (ACC) of patients with schizophrenia. We investigate the status of astroglial integrity indexed by ACC myo-inositol at the onset and over the first 6 months of treatment of first episode schizophrenia. We employed 7 T magnetic resonance spectroscopy (1H-MRS) and quantified myo-inositol spectra at the dorsal ACC in 31 participants; 21 patients with schizophrenia with median lifetime antipsychotic exposure of less than 3 days, followed up after 6 months of treatment, and 10 healthy subjects scanned twice over the same period. We studied the time by group interaction for myo-inositol after adjusting for gender and age. We report significant reduction in myo-inositol concentration in the ACC in schizophrenia at an early, untreated state of acute illness that becomes insignificant over time, after instituting early intervention. This trajectory indicates that dynamic astroglial changes are likely to operate in the early stages of schizophrenia. MRS myo-inositol may be a critical marker of amelioration of active psychosis in early stages of schizophrenia.